AI assistant
Zai Lab Ltd — Director's Dealing 2023
Jul 17, 2023
31208_dirs_2023-07-17_74af776c-bc04-40c0-9620-0aa3a85177cd.zip
Director's Dealing
Open in viewerOpens in your device viewer
SEC Form 3 — Initial Statement of Beneficial Ownership
Issuer: Zai Lab Ltd (ZLAB)
CIK: 0001704292
Period of Report: 2023-07-07
Reporting Person: Chen Yajing (N/A)
Holdings (Non-Derivative)
| Security | Shares | Ownership |
|---|---|---|
| American Depositary Shares | 45964 | Direct |
Holdings (Derivative)
| Security | Exercise Price | Expiration | Underlying | Shares | Ownership |
|---|---|---|---|---|---|
| Stock Option (Right to Buy) | $102.75 | 2031-10-01 | American Depositary Shares (8000) | Direct | |
| Stock Option (Right to Buy) | $104.42 | 2031-11-01 | American Depositary Shares (5000) | Direct | |
| Stock Option (Right to Buy) | $45.47 | 2032-04-01 | American Depositary Shares (20000) | Direct | |
| Stock Option (Right to Buy) | $33.95 | 2033-04-03 | American Depositary Shares (26000) | Direct |
Footnotes
F1: Each Stock Option is exercisable for one American Depositary Share, which represents ten Ordinary Shares of the issuer.
F2: The option vests in equal annual installments over five years beginning on 10/01/2022, the first anniversary of the date of grant.
F3: The option vests in equal annual installments over four years beginning on 11/01/2022, the first anniversary of the date of grant.
F4: The option vests in equal annual installments over five years beginning on 04/01/2023, the first anniversary of the date of grant.
F5: The option vests in equal annual installments over four years beginning on 04/03/2024, the first anniversary of the date of grant.